Journal ArticleOPEN ACCESS

Cardiovascular Safety of Oral Antidiabetic Agents: The Insulin Secretagogues

  • Caulfield M
  • O’Brien K
Clinical Diabetes (2002) 20(2) 81-84
DOI: 10.2337/diaclin.20.2.81
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In BriefThis article reviews and dispels concerns about the potential cardiotoxicity of insulin and oral diabetes drugs, specifically the insulin secretagogues, in patients with type 2 diabetes. The authors focus on insulin and the sulfonylurea drugs but also briefly discuss meglitinide analogs.

Cite

CITATION STYLE

APA

Caulfield, M. T., & O’Brien, K. D. (2002). Cardiovascular Safety of Oral Antidiabetic Agents: The Insulin Secretagogues. Clinical Diabetes, 20(2), 81–84. https://doi.org/10.2337/diaclin.20.2.81

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free